Chrysanthemic Acid, Ethyl Ester

Chrysanthemic Acid, Ethyl Ester

SCHEMBL294267

CCOC(=O)C1C(C=C(C)C)C1(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 1.00
CYP1A2 P05177 3/20 0.49
CYP2C19 P33261 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 4/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ALOX15 P16050 1/20 0.40
TRPV1 Q8NER1 1/20 0.38
ADRA2A P08913 1/20 0.38
CNR1 P21554 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chrysanthemic Acid, Ethyl Ester SCHEMBL6054986 1.00 LMNA (1.00) LMNACYP1A2CYP2C19TDP1CYP3A4
Chrysanthemic Acid, Ethyl Ester SCHEMBL3676624 1.00 LMNA (1.00) LMNACYP1A2CYP2C19TDP1CYP3A4
Chrysanthemic Acid, Ethyl Ester SCHEMBL10712272 1.00 LMNA (1.00) LMNACYP1A2CYP2C19TDP1CYP3A4
Chrysanthemic Acid, Ethyl Ester SCHEMBL18231332 1.00 LMNA (1.00) LMNACYP1A2CYP2C19TDP1CYP3A4
Chrysanthemic Acid, Ethyl Ester SCHEMBL10846022 1.00 LMNA (1.00) LMNACYP1A2CYP2C19TDP1CYP3A4
Chrysanthemic Acid, Ethyl Ester SCHEMBL28202971 0.98 LMNA (0.97) LMNACYP1A2CYP2C19TDP1CYP3A4
SCHEMBL296159 0.86 LMNA (0.76) LMNACYP1A2CYP2C19TDP1CYP3A4
SCHEMBL10948910 0.86 LMNA (0.75) LMNACYP1A2CYP2C19TDP1CYP3A4
SCHEMBL10946849 0.86 LMNA (0.75) LMNACYP1A2CYP2C19TDP1CYP3A4
SCHEMBL10828657 0.86 LMNA (0.75) LMNACYP1A2CYP2C19TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12635710-B2 Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions EASTMAN CHEMICAL COMPANY (US) 2026-05-26 US claimed
CN-120077127-A Novel esterase mutants and their use as stereoselective catalysts 恩德拉股份公司 2025-05-30 CN claimed
CN-222709540-U Ethyl chrysanthemate configuration stirring device 甘肃泰鑫隆新材料有限公司 2025-04-04 CN claimed
CN-119752967-A Stable and efficient escherichia coli gene editing system and application thereof 浙江工业大学 2025-04-04 CN claimed
CN-119630794-A Modified esterases 天野酶制品株式会社 2025-03-14 CN claimed
CN-119490433-A Diazotization process for producing ethyl chrysanthemate 湖北中农化工有限公司 2025-02-21 CN claimed
CN-119330826-A Method for efficiently preparing ethyl chrysanthemate by using Beta/CuCl nano molecular sieve catalyst 临沂广辰化工有限公司 2025-01-21 CN claimed
CN-119191936-A Desolventizing process for producing ethyl chrysanthemate 湖北中农化工有限公司 2024-12-27 CN claimed
CN-118955288-A Cyclization process for producing ethyl chrysanthemate 湖北中农化工有限公司 2024-11-15 CN claimed
CN-118594437-A Ethyl chrysanthemate cyclization reaction processing device and processing method 临沂广辰化工有限公司 2024-09-06 CN claimed
CN-104448415-A Composite material for air permeability medical gloves and preparation method of composite material SUZHOU BEC BIOLOGICAL TECHNOLOGY CO LTD 2015-03-25 CN claimed
CN-104312505-A Adhesive for solid wood NING YIWEI 2015-01-28 CN claimed
CN-104293271-A Novel solid wood adhesive WANG LU 2015-01-21 CN claimed
CN-102127040-B Preparation method of 6,6-dimethyl-3-oxadicyclo[3.1.0]hexane-2,4-diketone XI AN CAIJING OPTO ELECTRICAL SCIENCE & TECHNOLOGY CO LTD 2013-05-01 CN claimed
WO-2008015533-A2 POROUS DIELECTRIC LAYERS OBTAINED FROM PORE -FORMING PRECURSORS L'AIR LIQUIDE-SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (US) 2008-02-07 WO claimed
US-6750370-B2 CHEMICAL INTERMEDIATE FOR SYNTHETIC PYRETHROIDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-06-15 US claimed
US-20030032839-A1 Process for racemizing optically active vinyl-substituted cyclopropanecarboxylic acid compound PANASONIC CORPORATION (JP) 2003-02-13 US claimed
US-5281534-A Stereospecific, deesterification RHONE-POULENC INC. (US) 1994-01-25 US claimed
US-4788323-A Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-11-29 US claimed
US-4659864-A USING ALUMINUM BORMIDE AND A HYDROPEROXIDE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1987-04-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12635710-B2 Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions FABP2, FABP1, VIP LMNA 1802/4885CYP1A2 2154/4885CYP2C19 2565/4885
US-20030032839-A1 Process for racemizing optically active vinyl-substituted cyclopropanecarboxylic acid compound NOS1, CYP1B1, CBR1 LMNA 2790/4885CYP1A2 44/4885CYP2C19 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.